This direct access to physician offices as well as to hospitals and laboratories will be especially beneficial when it comes time to educate the point of care marketplace on the cardiac products we have under development, such as the prothrombin test
due out in the US marketplace in 2006.
IVMD's initial products and technologies are in various stages of development, including a prothrombin test
device that is significantly less expensive, more compact and easier to use than those presently in the marketplace; a non-invasive glucose monitoring system for diabetics; a fetal monitoring system that can be used at home by mothers-to-be to check on the well-being of their unborn child; and a product that can predict the onset of a woman's labor as far as a month in advance.
The Health Department investigation showed that an incorrect laboratory formula number was used -- causing an error in the calculation of the Prothrombin Test
(often referred to as a Protime Test or PT, which checks the rate at which blood is clotting).